ArticleNature communications2023

Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy.

Mengxue Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.